Mouse Anti-Rat VGLUT2 Monoclonal IgG1 Antibody
Vesicular Glutamate Transporter 2 (VGLUT2), encoded by SLC17A6, is an ATP-dependent, chloride-sensitive transporter essential for loading glutamate into synaptic vesicles. Alongside VGLUT1 (BNPI) and VGLUT3, VGLUT2 plays a pivotal role in excitatory neurotransmission. Its expression is regionally distinct and complementary to VGLUT1: while VGLUT1 predominates in telencephalic regions, VGLUT2 is highly expressed in the diencephalon and lower brainstem—areas critical for autonomic control, sensory integration, and motor coordination.
VGLUT2 is also expressed in rat pinealocytes and pancreatic α and β cells, where it responds to glucose levels, suggesting a broader role in neuroendocrine signaling. This transporter is particularly relevant in the context of neurodegenerative diseases, as its dysregulation has been implicated in conditions such as Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Huntington’s disease. Its involvement in glutamate homeostasis and excitotoxicity positions VGLUT2 as a key molecular target for understanding disease mechanisms and developing therapeutic interventions.
Although VGLUT3 shares approximately 72% sequence homology with VGLUT2 and VGLUT1, each isoform exhibits distinct spatial and functional profiles. VGLUT2’s unique distribution and regulatory mechanisms make it a critical focus in neuroscience research, particularly in studies of synaptic plasticity, circuit dysfunction, and neurodegeneration.
This Mouse Anti-Rat VGLUT2 Monoclonal IgG1 Antibody is manufactured in Canada by StressMarq.
![Human [Ala31] IGF-I](https://eaglebio.com/wp-content/uploads/2025/08/GroPep-logo-header-1-418x418.png){kind=logo}
